Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice
Quartz
Thu, 02/15/24 - 07:20 pm
Tags:
Novo Nordisk, Lars Fruergaard Jorgensen, Ozempic, Wegovy, weight loss
3 questions hanging over the Novo-Catalent deal
Pharma Voice
Wed, 02/14/24 - 10:55 am
Tags:
Novo Nordisk, Catalent, drug manufacturing, Ozempic Wegovy, Eli Lilly
Novo Nordisk's controlling shareholder plans to invest about $35 bln by 2030
Reuters
Mon, 02/12/24 - 11:19 pm
Tags:
Novo Nordisk, Novo Holdings
Weight-loss drugs tied to benefit after hip replacement
Reuters
Mon, 02/12/24 - 10:26 am
Tags:
hip replacements, GLP-1 agonist, Ozempic, Novo Nordisk
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
Tags:
earnings, COVID-19, GLP-1 agonist, JNJ, Bristol Myers Squibb, Pfizer, AstraZeneca, Sanofi, Eli Lilly, Novo Nordisk
As Catalent prepares to join Novo family, CDMO's sales continue to slide
Fierce Pharma
Fri, 02/9/24 - 11:21 am
Tags:
Catalent, CDMOs, earnings, Novo Nordisk
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
Tags:
depression, weight loss, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Mounjaro
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
Motley Fool
Thu, 02/8/24 - 10:01 pm
Tags:
Merck, Eli Lilly, Novo Nordisk, weight loss
Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic
Fierce Pharma
Wed, 02/7/24 - 09:15 pm
Tags:
Novo Nordisk, executive pay, Lars Fruergaard Jorgensen, Pharma CEOs
FDA finds control lapses at Catalent plant being sold to Novo
Reuters
Tue, 02/6/24 - 11:36 pm
Tags:
FDA, drug manufacturing, regulatory, Novo Nordisk, Catalent
Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains
Fierce Pharma
Tue, 02/6/24 - 09:33 am
Tags:
Eli Lilly, tirzepatide, Novo Nordisk, Zepbound, Mounjaro
Novo Holdings acquires Catalent in $16.5B deal, aiming to boost Wegovy production as demand soars
Medical Marketing and Media
Mon, 02/5/24 - 11:06 pm
Tags:
Novo Nordisk, Catalent, drug manufacturing, Wegovy, M&A
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Tags:
Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Mounjaro, obesity, weight loss
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
CNBC
Mon, 02/5/24 - 10:10 am
Tags:
Novo Nordisk, Catalent, drug manufacturing, M&A, Wegovy, Ozempic
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 02/2/24 - 11:50 am
Tags:
Abbott Labs, Novo Nordisk, Eli Lilly, weight loss, Protality
Novo Nordisk doubles stock of Wegovy starter doses but supply constraints persist: CEO
Fierce Pharma
Wed, 01/31/24 - 11:56 am
Tags:
Novo Nordisk, Wegovey, earnings, Ozempic
Novo Nordisk R&D spend jumps 35% thanks to soaring sales as oral obesity plans advance
Fierce Biotech
Wed, 01/31/24 - 11:55 am
Tags:
Novo Nordisk, R&D, obesity, amycretin
As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke
Fierce Pharma
Tue, 01/30/24 - 09:26 pm
Tags:
AstraZeneca, Novo Nordisk, legal, Inflation Reduction Act, HHS, drug pricing
Will Novo Nordisk Be a $1 Trillion Company by 2030?
Motley Fool
Tue, 01/30/24 - 10:40 am
Tags:
Novo Nordisk, obesity, diabetes, kidney disease
2 Rising Biotechs That Could Become the Next Novo Nordisk
Motley Fool
Mon, 01/29/24 - 11:04 am
Tags:
Novo Nordisk, Madrigal Pharmaceuticals, Viking Therapeutics, NASH

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.